ArticleBMC veterinary research2025
Serum cholesterol disturbances in dogs with common endocrinopathies at the time of diagnosis: a retrospective study.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Andrographolide alleviates type 2 diabetic nephropathy through suppressing PI3K/AKT1/RRM2-triggered oxeiptosis.Journal of advanced research · 2026Article
- Agreeing Language in Veterinary Endocrinology (ALIVE): Hypothyroidism, Hyperthyroidism, (Euglycaemic) Diabetic Ketosis/Ketoacidosis, and Diabetic Remission-A Modified Delphi-Method-Based System to Create Consensus Definitions.Veterinary sciences · 2026Article
- Agreeing Language in Veterinary Endocrinology (ALIVE): Cushing's Syndrome and Hypoadrenocorticism-A Modified Delphi-Method-Based System to Create Consensus Definitions.Veterinary sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough dyslipidemia is commonly reported in dogs, comparative data on the magnitude of serum cholesterol disturbances have not been reported. We aimed to describe the severity of hyper- and hypocholesterolemia in dogs with common endocrinopathies and to evaluate its association with common laboratory parameters. Medical records were reviewed over a decade (2011-2022) for dogs with hypothyroidism, diabetes mellitus (DM), hyperadrenocorticism (HAC), or hypoadrenocorticism (HA), and included signalment, common laboratory and diagnostic imaging parameters, comorbidities, and medications. This retrospective study included 53 dogs with hypothyroidism, 54 with DM, 62 with HAC, and 79 with HA.
resultsMedians [range] of serum cholesterol concentration ([Chol]
conclusionsSerum cholesterol concentration can serve as a valuable tool to suspect certain canine endocrinopathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.